Cargando…
An epigenetic signature of adhesion molecules predicts poor prognosis of ovarian cancer patients
DNA methylation is a promising biomarker for cancer. The epigenetic effects of cell adhesion molecules may affect the therapeutic outcome and the present study examined their effects on survival in ovarian cancer. We integrated methylomics and genomics datasets in The Cancer Genome Atlas (n = 391) a...
Autores principales: | Chang, Ping-Ying, Liao, Yu-Ping, Wang, Hui-Chen, Chen, Yu-Chih, Huang, Rui-Lan, Wang, Yu-Chi, Yuan, Chiou-Chung, Lai, Hung-Cheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581121/ https://www.ncbi.nlm.nih.gov/pubmed/28881822 http://dx.doi.org/10.18632/oncotarget.18515 |
Ejemplares similares
-
Cyclin D1 overexpression correlates with poor tumor differentiation and prognosis in gastric cancer
por: Shan, Yan-Shen, et al.
Publicado: (2017) -
Pyruvate kinase M2 is a poor prognostic marker of and a therapeutic target in ovarian cancer
por: Chao, Tai-Kuang, et al.
Publicado: (2017) -
Epigenomic Profiling of Epithelial Ovarian Cancer Stem-Cell Differentiation Reveals GPD1 Associated Immune Suppressive Microenvironment and Poor Prognosis
por: Chen, Lin-Yu, et al.
Publicado: (2022) -
Overexpression of PRC1 indicates a poor prognosis in ovarian cancer
por: Bu, Hualei, et al.
Publicado: (2020) -
The feasibility of detecting endometrial and ovarian cancer using DNA methylation biomarkers in cervical scrapings
por: Chang, Cheng-Chang, et al.
Publicado: (2018)